Add Company
Join Now

twoXAR Incorporated Revenue and Competitors

License our Company Data API

Location

$14.3M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • twoXAR Incorporated's estimated annual revenue is currently $3.6M per year.(i)
    • 0
  • twoXAR Incorporated's total funding is $14.3M.

Employee Data

    00
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.3M6811%$3MN/A
#2
$1.4M7N/AN/AN/A
#3
$15.7M78-26%$176.6MN/A
#4
$39060M980350%$30 b$234.4B
#5
$130.9M651N/AN/AN/A
#6
$25.7M161N/AN/AN/A
#7
$124.8M9101%$567.2M$2.2B
#8
$1.2M14N/AN/AN/A
#9
$0.9M6N/AN/AN/A
#10
$2360M48047%$22.5M$10.7B
#11
$12.2M79N/AN/AN/A
#12
$275.4M15547%N/A$4.4B
#13
$11.2M723%N/AN/A
#14
$12.6M57-15%N/AN/A
#15
$0.1M4N/AN/AN/A
#16
$2.7M27N/AN/AN/A
#17
$87.4M564N/AN/AN/A
#18
$46.5M2332%$396M$424.9M
#19
$8.4M54N/AN/AN/A
#20
$0.5M9N/AN/AN/A
Add Company

keywords:N/A

$14.3M

Total Funding

N/A

Number of Employees

$3.6M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

twoXAR Incorporated News

2022-04-19 - Artificial Intelligence (AI) in Drug Discovery Market Industry ...

... Cyclica Inc., Numerate, NuMedii, Inc., Envisagenics., twoXAR, Incorporated, OWKIN, INC., XtalPi Inc., BERG LLC, among other domestic and global players.

2022-04-17 - AI for Drug Discovery Market 2022 to See Major Growth by ...

Atomwise Inc., Insilico Medicine, BIOAGE, Numerate, NuMedii Inc., Envisagenics, Cloud Pharmaceuticals Inc., BenevolentAI, twoXAR Incorporated, Exscientia.

2022-04-17 - Artificial Intelligence (AI) in Drug Discovery Market 2022–2028 ...

Cloud Pharmaceuticals, Inc ... twoXAR, Incorporated ... Exscientia, Cyclica, Numerate, NuMedii, Envisagenics, twoXAR, Incorporated, OWKIN, XtalPi, BERG LLC.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$249.5M0N/A$240M
#2
$14.9M0N/A$65M
#3
$16.1M0N/A$108.5M
#4
$24.8M0N/AN/A
#5
$13.1M0N/A$73.1M